Schizophrenia

Schizophrenia is diagnosed through comprehensive psychiatric evaluation assessing symptoms, history, and functioning. Diagnostic criteria require: continuous signs for at least 6 months; at least 1 month of active-phase symptoms including two or more of delusions, hallucinations, disorganized speech, disorganized/catatonic behavior, or negative symptoms (at least one must be delusions, hallucinations, or disorganized speech); and significant functional impairment. Medical evaluation rules out substance-induced psychosis, medical conditions, and medication effects. We distinguish schizophrenia from schizoaffective disorder, bipolar disorder with psychosis, and other conditions.

Schizophrenia results from complex interactions between genetic, neurobiological, and environmental factors. Genetics play a significant role—having a first-degree relative with schizophrenia increases risk to about 10% (compared to ~1% in general population). Brain differences in structure and neurotransmitter systems (particularly dopamine) are involved. Environmental factors that may contribute include prenatal infections or malnutrition, birth complications, urban upbringing, migration, childhood adversity, and cannabis use during adolescence. No single factor causes schizophrenia—it develops from multiple interacting vulnerabilities. It is not caused by bad parenting, personal weakness, or anything the person did wrong.

Treatment includes: Antipsychotic medications—the cornerstone of treatment, effective for positive symptoms (hallucinations, delusions). Long-acting injectable antipsychotics provide consistent medication levels and eliminate daily pill-taking. Psychosocial interventions include cognitive behavioral therapy for psychosis (CBTp), social skills training, supported employment, and family psychoeducation. Coordinated Specialty Care (CSC) programs for first-episode psychosis combine medication, therapy, case management, and family support—with excellent outcomes. For treatment-resistant schizophrenia (defined as inadequate response to two antipsychotics), clozapine is the most effective option despite requiring blood monitoring.

Schizophrenia is a chronic condition requiring ongoing treatment, but "recovery" is absolutely achievable. Recovery doesn't necessarily mean being symptom-free—it means living a meaningful, satisfying life with purpose, hope, and connections despite having schizophrenia. With proper medication and support, many people with schizophrenia work, have relationships, live independently, and pursue their goals. Outcomes are better than often assumed: some people have only one episode; many achieve long-term stability; and early intervention—especially for first-episode psychosis—significantly improves prognosis. Continuous treatment prevents relapse and protects functioning.

Antipsychotic medications are the primary treatment. Second-generation (atypical) antipsychotics commonly used include risperidone (Risperdal), olanzapine (Zyprexa), quetiapine (Seroquel), aripiprazole (Abilify), paliperidone (Invega), lurasidone (Latuda), and ziprasidone (Geodon). Long-acting injectable (LAI) formulations—including Risperdal Consta, Invega Sustenna/Trinza, Abilify Maintena, and others—provide consistent medication levels and are increasingly recommended, especially after first episode. First-generation antipsychotics (haloperidol, fluphenazine) remain effective options. Clozapine (Clozaril) is the most effective for treatment-resistant schizophrenia but requires regular blood monitoring. We individualize selection based on symptoms, side effect profile, and patient preference.

Yes, schizophrenia commonly co-occurs with other conditions. Substance use disorders affect about 50% of people with schizophrenia—cannabis, alcohol, and tobacco are most common—and significantly worsen outcomes. Depression frequently co-occurs, sometimes requiring additional treatment. Anxiety disorders are common. Physical health conditions are more prevalent: people with schizophrenia have higher rates of metabolic syndrome, diabetes, cardiovascular disease, and die on average 15-20 years earlier—partly due to antipsychotic side effects, lifestyle factors, and inadequate medical care. Schizoaffective disorder involves schizophrenia symptoms plus significant mood episodes. Comprehensive care addresses all conditions.

Seek help if you or a loved one experiences: hearing voices or seeing things others don't; believing things that others say aren't true; confused, disorganized thinking or speech; significant personality or behavior changes; increasing social withdrawal and isolation; declining self-care; difficulty distinguishing what's real; or unusual suspiciousness or paranoia. Early intervention is crucial—especially for first-episode psychosis. The longer psychosis goes untreated, the worse outcomes tend to be. If someone is in crisis—severely disorganized, at risk of harm, or unable to care for themselves—seek emergency evaluation. For non-emergency concerns, call 430-288-5800 to schedule evaluation. Many families first notice changes—don't dismiss concerns about a loved one.